Both BLK and IVZ generate revenue through asset management, yet they sit in very different spots within the industry. This comparison matters for investors considering a large, diversified global platform against a smaller player focused on a multi-year turnaround. Each remains sensitive to market levels, fund flows, and fee pressures, though their scale, product mix, and growth trajectories differ in meaningful ways. From what I see, clarifying these contrasts can help determine which profile aligns better with specific objectives in the current environment.
BLK stands as the largest investment manager globally, covering public markets, private markets, and financial technology. Its latest reported quarter showed revenue near $7.1 billion, up about 31% year over year, with AUM hitting a record of roughly $15.3 trillion. Operating margin reached approximately 45.9%, a multi-year high, driven by solid iShares ETF inflows and growth in private credit and infrastructure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Price action has remained steady rather than volatile, with the shares holding in a range and posting modest gains over recent months. Support has come from scale benefits, recurring technology revenue, and moves into tokenization. The primary considerations include a premium valuation and exposure to any slowdown in ETF flows or broader fee compression.
IVZ operates as a global independent asset manager, recognized especially for its QQQ ETF tracking the Nasdaq-100, plus a range of active, passive, and alternative strategies. In the most recent quarter, adjusted earnings per share rose sharply year over year and adjusted operating margin expanded to about 37.5%. Record net long-term inflows reached roughly $45 billion, with annualized long-term organic growth near 8.5%.
AUM climbed to approximately $2.47 trillion, up more than 20% year over year, aided by QQQ demand and market gains. Even with improving fundamentals, recent price action has softened, with the stock pulling back over the past month and sitting below its 50-day moving average while staying above longer-term trends. Optimism around inflows and margin expansion sits alongside caution on fee pressure from lower-cost passive products.
The most obvious distinction remains scale. BLK's roughly $15.3 trillion AUM far exceeds IVZ's approximately $2.5 trillion, providing broader diversification across asset classes and regions plus a growing technology-services revenue line. Invesco shows greater concentration around its ETF and index offerings, especially QQQ, which fuels much of its recent inflow strength but also ties performance more closely to mega-cap technology sentiment.
Valuation metrics favor IVZ with a lower earnings multiple and higher dividend yield, reflecting its smaller size and historically narrower margins. BLK's premium rests on margins above 45% and more recurring, platform-style revenue. Growth momentum in percentage terms leans toward IVZ on organic inflows, while BLK leads in absolute net new assets and margin consistency.
Risk factors also diverge. BLK's size positions it as an industry bellwether more exposed to broad market declines, whereas IVZ encounters sharper fee-compression risks and execution challenges in its turnaround. Both face equity and fixed-income market swings, yet IVZ's more concentrated product set tends to produce greater volatility in results and share price.
Based on observable factors, Tickeron's AI would likely tilt toward BLK in the present setting, though not overwhelmingly. The combination of record AUM, expanding margins, diversified revenue, and steadier recent price action points to more consistent trend stability and stronger relative positioning than Invesco's softer near-term momentum. IVZ offers an attractive turnaround narrative with accelerating inflows and a lower valuation that could drive outperformance if sustained. Still, given BLK's more consistent fundamentals and lower volatility, a probabilistic, trend-oriented model would probably assign it a higher confidence score at present while acknowledging IVZ's higher-beta upside potential for risk-tolerant investors.
When evaluating systematic options for names like these, I often review Tickeron’s AI Trading Bots. They cover thousands of tickers across different timeframes and strategies, and the platform highlights stronger performers in the current market through its trending section. This gives a practical way to explore automated approaches that align with momentum, mean-reversion, or trend strategies without building signals manually. I find it useful for comparing how different bots might fit the risk profiles seen in asset managers today.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BLK moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on BLK as a result. In 44 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The 10-day moving average for BLK crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +3.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLK advanced for three days, in 194 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 151 of 293 cases where BLK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for BLK moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 19 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 64 cases where BLK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
BLK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. BLK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.169) is normal, around the industry mean (2.412). P/E Ratio (27.817) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.898) is also within normal values, averaging (1.319). Dividend Yield (0.019) settles around the average of (0.270) among similar stocks. P/S Ratio (6.270) is also within normal values, averaging (15.694).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment and risk management services
Industry InvestmentManagers